{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:49:28Z","timestamp":1791492568193,"version":"4.3.4"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41443-025-01194-4","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:33:26Z","timestamp":1760704406000},"page":"717-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cChemical Seduction\u201d: a narrative review of the complex impact of recreational drugs on sexual function"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-4202","authenticated-orcid":false,"given":"Nir","family":"Meller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Kitrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1194_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/S1740022820000108","volume":"16","author":"AMD Moore","year":"2021","unstructured":"Moore AMD, Pithavadian R. Aphrodisiacs in the global history of medical thought. J Glob Hist. 2021;16:24\u201343.","journal-title":"J Glob Hist"},{"key":"1194_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0973-7847.112832","volume":"7","author":"J Ali","year":"2013","unstructured":"Ali J, Ansari S, Kotta S. Exploring scientifically proven herbal aphrodisiacs. Pharmacogn Rev. 2013;7:1\u20137.","journal-title":"Pharmacogn Rev"},{"key":"1194_CR3","doi-asserted-by":"publisher","first-page":"548704","DOI":"10.3389\/fnins.2020.548704","volume":"14","author":"H Donnadieu-Rigole","year":"2020","unstructured":"Donnadieu-Rigole H, Peyri\u00e8re H, Benyamina A, Karila L. Complications related to sexualized drug use: what can we learn from literature? Front Neurosci. 2020;14:548704.","journal-title":"Front Neurosci"},{"key":"1194_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJMoa067423","volume":"357","author":"ST Lindau","year":"2007","unstructured":"Lindau ST, Schumm LP, Laumann EO, Levinson W, O\u2019Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357:762\u201374.","journal-title":"N Engl J Med"},{"key":"1194_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/sextrans-2015-052094","volume":"92","author":"KR Mitchell","year":"2016","unstructured":"Mitchell KR, Prah P, Mercer CH, Datta J, Tanton C, Macdowall W, et al. Medicated sex in Britain: evidence from the third National Survey of Sexual Attitudes and Lifestyles. Sex Transm Infect. 2016;92:32\u201338.","journal-title":"Sex Transm Infect"},{"key":"1194_CR6","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.3390\/ijerph20032751","volume":"20","author":"D Incera-Fernandez","year":"2023","unstructured":"Incera-Fernandez D, Roman FJ, Moreno-Guillen S, Gamez-Guadix M. Understanding sexualized drug use: substances, reasons, consequences, and self-perceptions among men who have sex with men in Spain. Int J Environ Res Public Health. 2023;20:3062.","journal-title":"Int J Environ Res Public Health"},{"key":"1194_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1743-6109.2007.00571.x","volume":"5","author":"G La Pera","year":"2008","unstructured":"La Pera G, Carderi A, Marianantoni Z, Peris F, Lentini M, Taggi F. Sexual dysfunction prior to first drug use among former drug addicts and its possible causal meaning on drug addiction: preliminary results. J Sex Med. 2008;5:164\u201372.","journal-title":"J Sex Med"},{"key":"1194_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/sextrans-2016-052695","volume":"93","author":"P Weatherburn","year":"2017","unstructured":"Weatherburn P, Hickson F, Reid D, Torres-Rueda S, Bourne A. Motivations and values associated with combining sex and illicit drugs (chemsex) among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2017;93:203\u20137.","journal-title":"Sex Transm Infect"},{"key":"1194_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2174\/1570159X15666161117151148","volume":"15","author":"R Giorgetti","year":"2017","unstructured":"Giorgetti R, Tagliabracci A, Schifano F, Zaami S, Marinelli E, Busardo FP. When chems meet sex: a rising phenomenon called chemsex. Curr Neuropharmacol. 2017;15:762\u201370.","journal-title":"Curr Neuropharmacol"},{"key":"1194_CR10","doi-asserted-by":"publisher","first-page":"13577","DOI":"10.3390\/ijerph192013645","volume":"19","author":"P Lopez de Juan Abad","year":"2022","unstructured":"Lopez de Juan Abad P, Arcos-Romero AI. Substance use in sexual relationships: association with sexual assertiveness and sexual satisfaction. Int J Environ Res Public Health. 2022;19:13577.","journal-title":"Int J Environ Res Public Health"},{"key":"1194_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.jsxm.2021.09.013","volume":"18","author":"FM Nimbi","year":"2021","unstructured":"Nimbi FM, Rosati F, Esposito RM, Stuart D, Simonelli C, Tambelli R. Sex in chemsex: sexual response, motivations, and sober sex in a group of Italian men who have sex with men with sexualized drug use. J Sex Med. 2021;18:1955\u201369.","journal-title":"J Sex Med"},{"key":"1194_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.drugpo.2016.09.007","volume":"38","author":"AJ Schmidt","year":"2016","unstructured":"Schmidt AJ, Bourne A, Weatherburn P, Reid D, Marcus U, Hickson F, et al. Illicit drug use among gay and bisexual men in 44 cities: findings from the European MSM Internet Survey (EMIS). Int J Drug Policy. 2016;38:4\u201312.","journal-title":"Int J Drug Policy"},{"key":"1194_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcph.266","volume":"54","author":"CM White","year":"2014","unstructured":"White CM. How MDMA\u2019s pharmacology and pharmacokinetics drive desired effects and harms. J Clin Pharmacol. 2014;54:245\u201352.","journal-title":"J Clin Pharmacol"},{"key":"1194_CR14","doi-asserted-by":"publisher","first-page":"997730","DOI":"10.3389\/fpubh.2022.997730","volume":"10","author":"JM Guerras","year":"2022","unstructured":"Guerras JM, Hoyos J, Donat M, de la Fuente L, Palma Diaz D, Ayerdi O, et al. Sexualized drug use among men who have sex with men in Madrid and Barcelona: the gateway to new drug use? Front Public Health. 2022;10:997730.","journal-title":"Front Public Health"},{"key":"1194_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/jhmas\/jrj039","volume":"61","author":"N Rasmussen","year":"2006","unstructured":"Rasmussen N. Making the first anti-depressant: amphetamine in American medicine, 1929-1950. J Hist Med Allied Sci. 2006;61:288\u2013323.","journal-title":"J Hist Med Allied Sci"},{"key":"1194_CR16","first-page":"CD007813","volume":"2018","author":"X Castells","year":"2018","unstructured":"Castells X, Blanco-Silvente L, Cunill R. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2018;2018:CD007813.","journal-title":"Cochrane Database Syst Rev"},{"key":"1194_CR17","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1074\/jbc.M805298200","volume":"284","author":"JS Goodwin","year":"2009","unstructured":"Goodwin JS, Larson GA, Swant J, Sen N, Javitch JA, Zahniser NR, et al. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. J Biol Chem. 2009;284:2978\u201389.","journal-title":"J Biol Chem"},{"key":"1194_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/jsm.12926","volume":"12","author":"NH Chou","year":"2015","unstructured":"Chou NH, Huang YJ, Jiann BP. The impact of illicit use of amphetamine on male sexual functions. J Sex Med. 2015;12:1694\u2013702.","journal-title":"J Sex Med"},{"key":"1194_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.yco.0000165592.52811.84","volume":"18","author":"JC Maxwell","year":"2005","unstructured":"Maxwell JC. Emerging research on methamphetamine. Curr Opin Psychiatry. 2005;18:235\u201340.","journal-title":"Curr Opin Psychiatry"},{"key":"1194_CR20","volume-title":"StatPearls [Internet]","author":"R Yasaei","year":"2025","unstructured":"Yasaei R, Saadabadi A. Methamphetamine. [Updated 2023 May 1]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535356\/ Available from:"},{"key":"1194_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s002130050880","volume":"142","author":"DF Fiorino","year":"1999","unstructured":"Fiorino DF, Phillips AG. Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization. Psychopharmacology (Berl). 1999;142:200\u20138.","journal-title":"Psychopharmacology (Berl)"},{"key":"1194_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2478\/nsad-2013-0035","volume":"30","author":"A Sk\u00e5rner","year":"2013","unstructured":"Sk\u00e5rner A, Svensson B. Amphetamine use and sexual practices. Nord Stud Alcohol Drugs. 2013;30:403\u201323.","journal-title":"Nord Stud Alcohol Drugs"},{"key":"1194_CR23","doi-asserted-by":"publisher","DOI":"10.5812\/ijhrba.29640","volume":"5","author":"B Dolatshahi","year":"2016","unstructured":"Dolatshahi B, Farhoudian A, Falahatdoost M, Tavakoli M, Rezaie Dogahe E. A qualitative study of the relationship between methamphetamine abuse and sexual dysfunction in male substance abusers. Int J High Risk Behav Addict. 2016;5:e30637.","journal-title":"Int J High Risk Behav Addict"},{"key":"1194_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1389","volume":"9","author":"RS Calabro","year":"2019","unstructured":"Calabro RS, Cacciola A, Bruschetta D, Milardi D, Quattrini F, Sciarrone F, et al. Neuroanatomy and function of human sexual behavior: a neglected or unknown issue? Brain Behav. 2019;9:e01266.","journal-title":"Brain Behav"},{"key":"1194_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.physbeh.2004.08.018","volume":"83","author":"EM Hull","year":"2004","unstructured":"Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav. 2004;83:291\u2013307.","journal-title":"Physiol Behav"},{"key":"1194_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10461-005-1682-3","volume":"9","author":"SP Kurtz","year":"2005","unstructured":"Kurtz SP. Post-circuit blues: motivations and consequences of crystal meth use among gay men in Miami. AIDS Behav. 2005;9:63\u201372.","journal-title":"AIDS Behav"},{"key":"1194_CR27","first-page":"47","volume":"14","author":"A McKay","year":"2005","unstructured":"McKay A. Sexuality and substance use: the impact of tobacco, alcohol, and selected recreational drugs on sexual function. Can J Hum Sex. 2005;14:47\u201354.","journal-title":"Can J Hum Sex"},{"key":"1194_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/cap.2016.0130","volume":"27","author":"AA Joseph","year":"2017","unstructured":"Joseph AA, Reddy A. Excessive masturbation association with mixed amphetamine salts. J Child Adolesc Psychopharmacol. 2017;27:291\u20132.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1194_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/00926239508414646","volume":"21","author":"BD Bartlik","year":"1995","unstructured":"Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther. 1995;21:264\u201371.","journal-title":"J Sex Marital Ther"},{"key":"1194_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urology.2020.04.081","volume":"142","author":"LA Levine","year":"2020","unstructured":"Levine LA, Betcher HK, Ziegelmann MJ, Bajic P. Amphetamine\/dextroamphetamine salts for delayed orgasm and anorgasmia in men: a pilot study. Urology. 2020;142:141\u20135.","journal-title":"Urology"},{"key":"1194_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4088\/JCP.v59n0709","volume":"59","author":"MP Kafka","year":"1998","unstructured":"Kafka MP, Prentky RA. Attention-deficit\/hyperactivity disorder in males with paraphilias and paraphilia-related disorders. J Clin Psychiatry. 1998;59:388\u201396.","journal-title":"J Clin Psychiatry"},{"key":"1194_CR32","volume-title":"Adderall prescribing information","author":"Food and Drug Administration","year":"2017","unstructured":"Food and Drug Administration. Adderall prescribing information. Silver Spring (MD): US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research; 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/011522s043lbl.pdf Available from:"},{"key":"1194_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1176\/ajp.2007.164.1.157","volume":"164","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang GJ, Fowler JS, Telang F, Jayne M, Wong C. Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry. 2007;164:157\u201360.","journal-title":"Am J Psychiatry"},{"key":"1194_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euroneuro.2014.11.020","volume":"25","author":"Y Schmid","year":"2015","unstructured":"Schmid Y, Hysek CM, Preller KH, Bosch OG, Bilderbeck AC, Rogers RD, et al. Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships. Eur Neuropsychopharmacol. 2015;25:17\u201325.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1194_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/B:AIBE.0000017528.39338.75","volume":"8","author":"CJ Reback","year":"2004","unstructured":"Reback CJ, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav. 2004;8:87\u201398.","journal-title":"AIDS Behav"},{"key":"1194_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/02791072.2001.10400569","volume":"33","author":"J Peugh","year":"2001","unstructured":"Peugh J, Belenko S. Alcohol, drugs and sexual function: a review. J Psychoactive Drugs. 2001;33:223\u201332.","journal-title":"J Psychoactive Drugs"},{"key":"1194_CR37","doi-asserted-by":"crossref","unstructured":"Palha AP, Esteves M Drugs of abuse and sexual functioning. In: Balon R, editor. Adv Psychosom Med. Basel: Karger; 2008. pp. 131-49.","DOI":"10.1159\/000126628"},{"key":"1194_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1743-6109.2007.00707.x","volume":"6","author":"J Bang-Ping","year":"2009","unstructured":"Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med. 2009;6:1072\u201380.","journal-title":"J Sex Med"},{"key":"1194_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2146\/news080049","volume":"65","author":"CA Thompson","year":"2008","unstructured":"Thompson CA. Pulmonary arterial hypertension seen in methamphetamine abusers. Am J Health Syst Pharm. 2008;65:1109\u201310.","journal-title":"Am J Health Syst Pharm"},{"key":"1194_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.addbeh.2004.02.013","volume":"29","author":"SJ Semple","year":"2004","unstructured":"Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav. 2004;29:807\u201310.","journal-title":"Addict Behav"},{"key":"1194_CR41","first-page":"917","volume":"165","author":"H Kalant","year":"2001","unstructured":"Kalant H. The pharmacology and toxicology of \u2018ecstasy\u2019 (MDMA) and related drugs. CMAJ. 2001;165:917\u201328.","journal-title":"CMAJ"},{"key":"1194_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/17470910802649470","volume":"4","author":"GJH Dumont","year":"2009","unstructured":"Dumont GJH, Sweep FCGJ, van der Steen R, Hermsen R, Donders ART, Touw DJ, et al. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci. 2009;4:359\u201366.","journal-title":"Soc Neurosci"},{"key":"1194_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.neuroscience.2007.02.032","volume":"146","author":"MR Thompson","year":"2007","unstructured":"Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS. A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4-methylenedioxymethamphetamine (ecstasy). Neuroscience. 2007;146:509\u201314.","journal-title":"Neuroscience"},{"key":"1194_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/08897077.2016.1267070","volume":"38","author":"JJ Palamar","year":"2017","unstructured":"Palamar JJ. There\u2019s something about Molly: the under-researched yet popular powder form of ecstasy in the United States. Subst Abuse. 2017;38:15\u201317.","journal-title":"Subst Abuse"},{"key":"1194_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00213-017-4650-5","volume":"235","author":"PC Dolder","year":"2018","unstructured":"Dolder PC, M\u00fcller F, Schmid Y, Borgwardt SJ, Liechti ME. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology (Berl). 2018;235:467\u201379.","journal-title":"Psychopharmacology (Berl)"},{"key":"1194_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/19371918.2020.1781013","volume":"35","author":"KK Rigg","year":"2020","unstructured":"Rigg KK, Mills A. Sexual risk behaviors among African Americans who use MDMA (Molly\/ecstasy): implications for HIV prevention. Soc Work Public Health. 2020;35:282\u201392.","journal-title":"Soc Work Public Health"},{"key":"1194_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s11013-021-09764-z","volume":"47","author":"R Colbert","year":"2023","unstructured":"Colbert R, Hughes S. Evenings with Molly: adult couples\u2019 use of MDMA for relationship enhancement. Cult Med Psychiatry. 2023;47:252\u201370.","journal-title":"Cult Med Psychiatry"},{"key":"1194_CR48","doi-asserted-by":"publisher","first-page":"666852","DOI":"10.3389\/fpsyt.2021.702838","volume":"12","author":"AC Wagner","year":"2021","unstructured":"Wagner AC, Liebman RE, Mithoefer AT, Mithoefer MC, Monson CM. Relational and growth outcomes following couples therapy with MDMA for PTSD. Front Psychiatry. 2021;12:666852.","journal-title":"Front Psychiatry"},{"key":"1194_CR49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10461-005-9059-1","volume":"10","author":"KP Theall","year":"2006","unstructured":"Theall KP, Elifson KW, Sterk CE. Sex, touch, and HIV risk among ecstasy users. AIDS Behav. 2006;10:169\u201378.","journal-title":"AIDS Behav"},{"key":"1194_CR50","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1360-0443.2006.01423.x","volume":"101","author":"CA Baylen","year":"2006","unstructured":"Baylen CA, Rosenberg H. A review of the acute subjective effects of MDMA\/ecstasy. Addiction. 2006;101:933\u201347.","journal-title":"Addiction"},{"key":"1194_CR51","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1081\/JA-200066810","volume":"40","author":"KB Levy","year":"2005","unstructured":"Levy KB, O\u2019Grady KE, Wish ED, Arria AM. An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Subst Use Misuse. 2005;40:1427\u201341.","journal-title":"Subst Use Misuse"},{"key":"1194_CR52","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1081\/JA-200066814","volume":"40","author":"K McElrath","year":"2005","unstructured":"McElrath K. MDMA and sexual behavior: ecstasy users\u2019 perceptions about sexuality and sexual risk. Subst Use Misuse. 2005;40:1461\u201377.","journal-title":"Subst Use Misuse"},{"key":"1194_CR53","first-page":"13","volume":"38","author":"Z Zemishlany","year":"2001","unstructured":"Zemishlany Z, Aizenberg D, Weizman A. Subjective effects of MDMA (Ecstasy) on human sexual function. Isr J Psychiatry Relat Sci. 2001;38:13\u201319.","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"1194_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/sxmrev\/qead046","volume":"12","author":"A Wexler","year":"2024","unstructured":"Wexler A, Dubinskaya A, Suyama J, Komisaruk BR, Anger J, Eilber K. Does MDMA have treatment potential in sexual dysfunction? A systematic review of outcomes across the female and male sexual response cycles. Sex Med Rev. 2024;12:26\u201334.","journal-title":"Sex Med Rev"},{"key":"1194_CR55","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.mehy.2004.11.044","volume":"64","author":"T Passie","year":"2005","unstructured":"Passie T, Hartmann U, Schneider U, Emrich HM, Kruger THC. Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA effects may be due to increased prolactin secretion. Med Hypotheses. 2005;64:899\u2013903.","journal-title":"Med Hypotheses"},{"key":"1194_CR56","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/and.12566","volume":"48","author":"NA Kumsar","year":"2016","unstructured":"Kumsar NA, Kumsar S, Dilbaz N. Sexual dysfunction in men diagnosed as substance use disorder. Andrologia. 2016;48:1229\u201335.","journal-title":"Andrologia"},{"key":"1194_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/YCO.0000000000000066","volume":"27","author":"JB Zawilska","year":"2014","unstructured":"Zawilska JB. Mephedrone and other cathinones. Curr Opin Psychiatry. 2014;27:256\u201362.","journal-title":"Curr Opin Psychiatry"},{"key":"1194_CR58","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1465-3362.2011.00288.x","volume":"30","author":"T Lea","year":"2011","unstructured":"Lea T, Reynolds R, De Wit J. Mephedrone use among same-sex attracted young people in Sydney, Australia. Drug Alcohol Rev. 2011;30:438\u201340.","journal-title":"Drug Alcohol Rev"},{"key":"1194_CR59","doi-asserted-by":"crossref","unstructured":"Baumann MH, Walters HM, Niello M, Sitte HH Neuropharmacology of synthetic cathinones. In: Baumann MH, editor. Advances in neuropharmacology. London: Elsevier; 2018. pp. 113-42.","DOI":"10.1007\/164_2018_178"},{"key":"1194_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","volume":"88","author":"MJ Valente","year":"2014","unstructured":"Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M. Khat and synthetic cathinones: a review. Arch Toxicol. 2014;88:15\u201345.","journal-title":"Arch Toxicol"},{"key":"1194_CR61","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1124\/jpet.111.184119","volume":"339","author":"GC Hadlock","year":"2011","unstructured":"Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, et al. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther. 2011;339:530\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"1194_CR62","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/QAD.0000000000000786","volume":"29","author":"M Bracchi","year":"2015","unstructured":"Bracchi M, Stuart D, Castles R, Khoo S, Back D, Boffito M. Increasing use of \u2018party drugs\u2019 in people living with HIV on antiretrovirals: a concern for patient safety. AIDS. 2015;29:1585\u201392.","journal-title":"AIDS"},{"key":"1194_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","volume":"231","author":"JB Zawilska","year":"2013","unstructured":"Zawilska JB, Wojcieszak J. Designer cathinones\u2014an emerging class of novel recreational drugs. Forensic Sci Int. 2013;231:42\u201353.","journal-title":"Forensic Sci Int"},{"key":"1194_CR64","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00213-010-2070-x","volume":"214","author":"F Schifano","year":"2011","unstructured":"Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, et al. Mephedrone (4-methylmethcathinone; \u2018meow meow\u2019): chemical, pharmacological and clinical issues. Psychopharmacology (Berl). 2011;214:593\u2013602.","journal-title":"Psychopharmacology (Berl)"},{"key":"1194_CR65","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/emj.2010.096636","volume":"28","author":"D James","year":"2011","unstructured":"James D, Adams RD, Spears R, Cooper G, Lupton DJ, Thompson JP, et al. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J. 2011;28:686\u20139.","journal-title":"Emerg Med J"},{"key":"1194_CR66","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/emj.2010.092288","volume":"28","author":"DM Wood","year":"2011","unstructured":"Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J. 2011;28:280\u20132.","journal-title":"Emerg Med J"},{"key":"1194_CR67","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1360-0443.2010.03130.x","volume":"106","author":"AR Winstock","year":"2011","unstructured":"Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F. Mephedrone, new kid for the chop? Addiction. 2011;106:154\u201361.","journal-title":"Addiction"},{"key":"1194_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1108\/17459261111174046","volume":"11","author":"MC Van Hout","year":"2011","unstructured":"Van Hout MC, Brennan R. \u2018Bump and grind\u2019: an exploratory study of mephedrone users\u2019 perceptions of sexuality and sexual risk. Drugs Alcohol Today. 2011;11:93\u2013103.","journal-title":"Drugs Alcohol Today"},{"key":"1194_CR69","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/sextrans-2015-052052","volume":"91","author":"A Bourne","year":"2015","unstructured":"Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. Illicit drug use in sexual settings (chemsex) and HIV\/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2015;91:564\u20138.","journal-title":"Sex Transm Infect"},{"key":"1194_CR70","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pharmthera.2008.10.003","volume":"121","author":"LP Carter","year":"2009","unstructured":"Carter LP, Koek W, France CP. Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther. 2009;121:100\u201314.","journal-title":"Pharmacol Ther"},{"key":"1194_CR71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0735-6757(91)90050-T","volume":"9","author":"JE Dyer","year":"1991","unstructured":"Dyer JE. \u03b3-Hydroxybutyrate: a health-food product producing coma and seizurelike activity. Am J Emerg Med. 1991;9:321\u20134.","journal-title":"Am J Emerg Med"},{"key":"1194_CR72","first-page":"354","volume":"92","author":"MT Steele","year":"1995","unstructured":"Steele MT, Watson WA. Acute poisoning from gamma hydroxybutyrate (GHB). Mo Med. 1995;92:354\u20137.","journal-title":"Mo Med"},{"key":"1194_CR73","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1172\/JCI119587","volume":"100","author":"E Van Cauter","year":"1997","unstructured":"Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, L\u2019Hermite-Bal\u00e9riaux M, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest. 1997;100:745\u201353.","journal-title":"J Clin Invest"},{"key":"1194_CR74","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainresbull.2016.02.002","volume":"126","author":"OG Bosch","year":"2016","unstructured":"Bosch OG, Seifritz E. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Res Bull. 2016;126:47\u201360.","journal-title":"Brain Res Bull"},{"key":"1194_CR75","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.smrv.2011.09.001","volume":"16","author":"R Boscolo-Berto","year":"2012","unstructured":"Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2012;16:431\u201343.","journal-title":"Sleep Med Rev"},{"key":"1194_CR76","first-page":"13235","volume":"65","author":"U.S. Drug Enforcement Administration (DEA)","year":"2000","unstructured":"U.S. Drug Enforcement Administration (DEA). Emergency scheduling of gamma hydroxybutyric acid and listing of gamma butyrolactone as List I chemical. Fed Regist. 2000;65:13235\u20138.","journal-title":"Fed Regist"},{"key":"1194_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/bs.irn.2015.02.005","volume":"120","author":"J Bearn","year":"2015","unstructured":"Bearn J, O\u2019Brien M. \u2018Addicted to euphoria\u2019: the history, clinical presentation, and management of party drug misuse. Int Rev Neurobiol. 2015;120:205\u201333.","journal-title":"Int Rev Neurobiol"},{"key":"1194_CR78","volume-title":"GHB and its precursor GBL: an emerging trend case study","author":"J Hillebrand","year":"2008","unstructured":"Hillebrand J, Olszewski D, Sedefov R. GHB and its precursor GBL: an emerging trend case study. Lisbon: EMCDDA; 2008."},{"key":"1194_CR79","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0006-8993(91)91700-B","volume":"566","author":"M Diana","year":"1991","unstructured":"Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa G. Low doses of \u03b3-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res. 1991;566:208\u201311.","journal-title":"Brain Res"},{"key":"1194_CR80","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1046\/j.1471-4159.2003.02037.x","volume":"87","author":"MP Castelli","year":"2003","unstructured":"Castelli MP, Ferraro L, Mocci I, Carta F, Carai MAM, Antonelli T, et al. Selective \u03b3-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative\/hypnotic effect of \u03b3-hydroxybutyric acid. J Neurochem. 2003;87:722\u201332.","journal-title":"J Neurochem"},{"key":"1194_CR81","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1124\/jpet.109.151845","volume":"330","author":"W Koek","year":"2009","unstructured":"Koek W, Mercer SL, Coop A, France CP. Behavioral effects of \u03b3-hydroxybutyrate, its precursor \u03b3-butyrolactone, and GABAB receptor agonists: time course and differential antagonism by the GABAB receptor antagonist CGP35348. J Pharmacol Exp Ther. 2009;330:876\u201383.","journal-title":"J Pharmacol Exp Ther"},{"key":"1194_CR82","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/15563650.2012.702218","volume":"50","author":"LJ Schep","year":"2012","unstructured":"Schep LJ, Knudsen K, Slaughter RJ, Vale JA, M\u00e9garbane B. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol. 2012;50:458\u201370.","journal-title":"Clin Toxicol"},{"key":"1194_CR83","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","volume":"27","author":"S Abanades","year":"2007","unstructured":"Abanades S, Farre M, Barral D, Torrens M, Closas N, Langohr K, et al. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. J Clin Psychopharmacol. 2007;27:625\u201333.","journal-title":"J Clin Psychopharmacol"},{"key":"1194_CR84","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/emj.2008.068403","volume":"28","author":"M Galicia","year":"2011","unstructured":"Galicia M, Nogue S, Miro O. Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients. Emerg Med J. 2011;28:462\u20136.","journal-title":"Emerg Med J"},{"key":"1194_CR85","first-page":"25","volume":"11","author":"F Romanelli","year":"2003","unstructured":"Romanelli F, Smith KM, Pomeroy C. Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men. Top HIV Med. 2003;11:25\u201332.","journal-title":"Top HIV Med"},{"key":"1194_CR86","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.drugalcdep.2007.07.009","volume":"92","author":"HR Sumnall","year":"2008","unstructured":"Sumnall HR, Woolfall K, Edwards S, Cole JC, Beynon CM. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend. 2008;92:286\u201390.","journal-title":"Drug Alcohol Depend"},{"key":"1194_CR87","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hup.2491","volume":"30","author":"M Kapitany-Foveny","year":"2015","unstructured":"Kapitany-Foveny M, Mervo B, Corazza O, K\u00f6k\u00f6nyei G, Farkas J, Urban R, et al. Enhancing sexual desire and experience: an investigation of the sexual correlates of gamma-hydroxybutyrate (GHB) use. Hum Psychopharmacol. 2015;30:276\u201384.","journal-title":"Hum Psychopharmacol"},{"key":"1194_CR88","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugpo.2005.11.002","volume":"17","author":"JJ Palamar","year":"2006","unstructured":"Palamar JJ, Halkitis PN. A qualitative analysis of GHB use among gay men: reasons for use despite potential adverse outcomes. Int J Drug Policy. 2006;17:23\u201328.","journal-title":"Int J Drug Policy"},{"key":"1194_CR89","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.euroneuro.2017.02.006","volume":"27","author":"OG Bosch","year":"2017","unstructured":"Bosch OG, Havranek MM, Baumberger A, Preller KH, von Rotz R, Herdener M, et al. Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans. Eur Neuropsychopharmacol. 2017;27:372\u201382.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1194_CR90","first-page":"143","volume":"5","author":"JJ Palamar","year":"2014","unstructured":"Palamar JJ, Kiang MV, Storholm ED, Halkitis PN. A qualitative descriptive study of perceived sexual effects of club drug use in gay and bisexual men. Psychol Sex. 2014;5:143\u201360.","journal-title":"Psychol Sex"},{"key":"1194_CR91","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/105504901750532111","volume":"10","author":"K Miotto","year":"2001","unstructured":"Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict. 2001;10:232\u201341.","journal-title":"Am J Addict"},{"key":"1194_CR92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/02791072.2008.10400639","volume":"40","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, Levounis P. Gamma hydroxybutyrate: an ethnographic study of recreational use and abuse. J Psychoactive Drugs. 2008;40:245\u201353.","journal-title":"J Psychoactive Drugs"},{"key":"1194_CR93","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1081\/JA-200066736","volume":"40","author":"JC Maxwell","year":"2005","unstructured":"Maxwell JC. Party drugs: properties, prevalence, patterns, and problems. Subst Use Misuse. 2005;40:1203\u201340.","journal-title":"Subst Use Misuse"},{"key":"1194_CR94","unstructured":"Reid S Daughter\u2019s death prompts fight on \u2018date rape\u2019 drug. The Guardian [Internet]. 1999 Oct 19. Available from: https:\/\/www.theguardian.com\/uk\/1999\/oct\/19\/stevenreid."},{"key":"1194_CR95","unstructured":"Shearing H. GHB: the drug used as a \u2018rapist\u2019s weapon of choice\u2019. BBC News [Internet]. 2020. https:\/\/www.bbc.com\/news\/health-51021606 Jan 6. Available from:"},{"key":"1194_CR96","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/cns.12063","volume":"19","author":"O Corazza","year":"2013","unstructured":"Corazza O, Assi S, Schifano F. From \u2018Special K\u2019 to \u2018Special M\u2019: the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther. 2013;19:454\u201360.","journal-title":"CNS Neurosci Ther"},{"key":"1194_CR97","first-page":"309","volume":"16","author":"O Bosch","year":"2012","unstructured":"Bosch O, Teltzrow R. Ecstatic anaesthesia: ketamine and GHB between medical use and self-experimentation. Appl Cardiopulm Pathophysiol. 2012;16:309\u201321.","journal-title":"Appl Cardiopulm Pathophysiol"},{"key":"1194_CR98","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/10253890.2021.1871600","volume":"24","author":"PJ Fitzgerald","year":"2021","unstructured":"Fitzgerald PJ, Kounelis-Wuillaume SK, Gheidi A, Morrow JD, Spencer-Segal JL, Watson BO. Sex- and stress-dependent effects of a single injection of ketamine on open field and forced swim behavior. Stress. 2021;24:857\u201365.","journal-title":"Stress"},{"key":"1194_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/146598901750132045","volume":"6","author":"P Dillon","year":"2001","unstructured":"Dillon P, Degenhardt L. Ketamine and GHB: new trends in club drug use? J Subst Use. 2001;6:11\u201319.","journal-title":"J Subst Use"},{"key":"1194_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-04832-9","volume":"12","author":"TSH Lee","year":"2022","unstructured":"Lee TSH, Liu YH, Huang YJ, Tang WK, Wang Y, Hu S, et al. Clinical and behavioral characteristics of individuals who used ketamine. Sci Rep. 2022;12:801.","journal-title":"Sci Rep"},{"key":"1194_CR101","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0736-4679(00)00162-1","volume":"18","author":"AL Weiner","year":"2000","unstructured":"Weiner AL, Vieira L, McKay CA, Bayer MJ. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med. 2000;18:447\u201351.","journal-title":"J Emerg Med"},{"key":"1194_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43746-x","volume":"9","author":"CC Li","year":"2019","unstructured":"Li CC, Wu ST, Cha TL, Sun GH, Yu DS, Meng E. A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan. Sci Rep. 2019;9:7240.","journal-title":"Sci Rep"},{"key":"1194_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207927","volume":"13","author":"SSD Yang","year":"2018","unstructured":"Yang SSD, Jang MY, Lee KH, Hsu WT, Chen YC, Chen WS, et al. Sexual and bladder dysfunction in male ketamine abusers: a large-scale questionnaire study. PLoS One. 2018;13:e0206772.","journal-title":"PLoS One"},{"key":"1194_CR104","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","volume":"107","author":"CJ Morgan","year":"2012","unstructured":"Morgan CJ, Curran HV. Independent scientific committee on drugs. Ketamine use: a review. Addiction. 2012;107:27\u201338.","journal-title":"Addiction"},{"key":"1194_CR105","first-page":"6","volume":"16","author":"SH Ng","year":"2010","unstructured":"Ng SH, Tse ML, Ng HW, Lau FL. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J. 2010;16:6\u201311.","journal-title":"Hong Kong Med J"},{"key":"1194_CR106","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/0310057X0203000323","volume":"30","author":"HR Pal","year":"2002","unstructured":"Pal HR, Berry N, Kumar R, Ray R. Ketamine dependence. Anaesth Intensive Care. 2002;30:382\u20134.","journal-title":"Anaesth Intensive Care"},{"key":"1194_CR107","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0376-8716(02)00243-0","volume":"69","author":"P Dillon","year":"2003","unstructured":"Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend. 2003;69:23\u201327.","journal-title":"Drug Alcohol Depend"},{"key":"1194_CR108","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0269881113477744","volume":"27","author":"CJ Morgan","year":"2013","unstructured":"Morgan CJ, Noronha LA, Muetzelfeldt M, Feilding A, Curran HV. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users. J Psychopharmacol. 2013;27:497\u2013506.","journal-title":"J Psychopharmacol"},{"key":"1194_CR109","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/da.22536","volume":"33","author":"S Sassano-Higgins","year":"2016","unstructured":"Sassano-Higgins S, Baron D, Juarez G, Esmaili N, Gold M. A review of ketamine abuse and diversion. Depress Anxiety. 2016;33:718\u201327.","journal-title":"Depress Anxiety"},{"key":"1194_CR110","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1071\/SH22140","volume":"19","author":"L Knoops","year":"2022","unstructured":"Knoops L, van Amsterdam J, Albers T, Brunt TM, van den Brink W. Slamsex in The Netherlands among men who have sex with men (MSM): use patterns, motives, and adverse effects. Sex Health. 2022;19:566\u201373.","journal-title":"Sex Health"},{"key":"1194_CR111","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/hiv.13160","volume":"22","author":"GG Whitlock","year":"2021","unstructured":"Whitlock GG, Protopapas K, Bernardino JI, Imaz A, Curran A, Stingone C, et al. Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services. HIV Med. 2021;22:944\u201357.","journal-title":"HIV Med"},{"key":"1194_CR112","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pbb.2017.12.004","volume":"165","author":"FA Guarraci","year":"2018","unstructured":"Guarraci FA, Gonzalez CMF, Lucero D, Womble PD, Abdel-Rahim H, DeVore J, et al. The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats. Pharmacol Biochem Behav. 2018;165:36\u201344.","journal-title":"Pharmacol Biochem Behav"},{"key":"1194_CR113","doi-asserted-by":"crossref","first-page":"12806","DOI":"10.3390\/ijms241612806","volume":"24","author":"SY Wu","year":"2023","unstructured":"Wu SY, Chao TC, Hsu CK, Chang HH, Yang SSD. Mechanism of social stress-related erectile dysfunction in mice: impaired parasympathetic neurotransmission and ketamine. Int J Mol Sci. 2023;24:12806.","journal-title":"Int J Mol Sci"},{"key":"1194_CR114","doi-asserted-by":"publisher","first-page":"1305245","DOI":"10.3389\/fpsyt.2024.1376646","volume":"15","author":"C Khalifian","year":"2024","unstructured":"Khalifian C, Rashkovsky K, Mitchell E, Bismark A, Wagner AC, Knopp KC. A novel framework for ketamine-assisted couple therapy. Front Psychiatry. 2024;15:1305245.","journal-title":"Front Psychiatry"},{"key":"1194_CR115","first-page":"65","volume":"8","author":"M Cornfield","year":"2024","unstructured":"Cornfield M, McBride S, La Torre JT, Zalewa D, Gallo J, Mahammadli M, et al. Exploring effects and experiences of ketamine in group couples therapy. J Psychedelic Stud. 2024;8:65\u201377.","journal-title":"J Psychedelic Stud"},{"key":"1194_CR116","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/02791072.2016.1156790","volume":"48","author":"B Suppiah","year":"2016","unstructured":"Suppiah B, Vicknasingam B, Singh D, Narayanan S. Erectile dysfunction among people who use ketamine and poly-drugs. J Psychoactive Drugs. 2016;48:86\u201392.","journal-title":"J Psychoactive Drugs"},{"key":"1194_CR117","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/jsxmed\/qdac052","volume":"20","author":"BE Jong","year":"2023","unstructured":"Jong BE, Chang SJ, Li CH, Yang SSD. Relationship between sexual and bladder dysfunction in women consuming ketamine. J Sex Med. 2023;20:467\u201374.","journal-title":"J Sex Med"},{"key":"1194_CR118","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/02791072.1982.10471907","volume":"14","author":"J Buffum","year":"1982","unstructured":"Buffum J. Pharmacosexology: the effects of drugs on sexual function\u2014a review. J Psychoactive Drugs. 1982;14:5\u201344.","journal-title":"J Psychoactive Drugs"},{"key":"1194_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108758","volume":"225","author":"TJ Starks","year":"2021","unstructured":"Starks TJ, Sauermilch D, Adebayo T, Kyre KD, Stratton MJ, Darbes LA. Day-level associations between drug use and sexual behavior in male couples: actor-partner interdependence modeling of timeline follow-back data. Drug Alcohol Depend. 2021;225:108758.","journal-title":"Drug Alcohol Depend"},{"key":"1194_CR120","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1086-5802(16)30472-7","volume":"39","author":"KM Smith","year":"1999","unstructured":"Smith KM. Drugs used in acquaintance rape. J Am Pharm Assoc (Wash). 1999;39:482\u20136.","journal-title":"J Am Pharm Assoc (Wash)"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01194-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01194-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:02:44Z","timestamp":1791489764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01194-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":120,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01194-4","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this narrative review study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}